デフォルト表紙
市場調査レポート
商品コード
1446545

医薬品無菌試験の市場規模、シェア、動向分析レポート:タイプ別、製品タイプ別、試験タイプ別、サンプル別、最終用途別、地域別、セグメント別予測、2024年~2030年

Pharmaceutical Sterility Testing Market Size, Share & Trends Analysis Report By Type (Outsourcing, In-house), By Product Type, By Test Type, By Sample, By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 267 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.74円
医薬品無菌試験の市場規模、シェア、動向分析レポート:タイプ別、製品タイプ別、試験タイプ別、サンプル別、最終用途別、地域別、セグメント別予測、2024年~2030年
出版日: 2024年02月22日
発行: Grand View Research
ページ情報: 英文 267 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医薬品無菌試験市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の医薬品無菌試験市場規模は2030年までに32億8,000万米ドルに達すると予測され、2024年から2030年までのCAGRは11.02%で成長すると予測されています。

世界の医薬品上市数の増加と政府投資の増加が、世界市場にプラスの影響を与えると予測されています。製薬会社が新薬の数々を市場に投入しているため、厳格な無菌試験プロトコルの需要も並行して急増しています。また、医薬品に対する厳しい規制要件が市場の成長をさらに後押ししています。このように、新薬上市の急増は、医薬品無菌試験市場にかつてない成長機会をもたらしました。

さらに、製薬業界における研究開発活動の重視の高まりは、医薬品無菌試験市場に大きな影響を与えています。製薬会社は革新的かつ先進的な製剤の発見と開発に積極的に関与しているため、これらの製品の安全性と有効性を確保するための堅牢な無菌試験プロトコルの必要性が高まっています。研究開発活動は、新しい医薬品、生物製剤、ワクチンの開発を促進し、規制要件を遵守するための包括的な無菌試験手法が必要となります。

さらに、医薬品承認のための規制機関による厳格な規制により、製薬企業は、これらの進化する基準を満たすために研究開発に多額の投資を行うようになっています。その結果、市場は規制状況に対応した最先端の試験ソリューションに対する需要が急増しています。例えば、2023年9月、ザルトリウスAGは、無菌試験装置からのサンプリング用のsterisartセプタムを発表しました。これは、二次汚染のリスクを軽減する膜ろ過法に基づく試験用の閉鎖システムです。このようなサービス開始により、市場での競争力が高まった。

さらに、医療用アンメットニーズへの対応と革新的な治療法の発見に取り組む製薬業界の姿勢は、堅牢な無菌試験プロトコルの重要性をさらに高めています。新たに上市される医薬品の安全性と有効性を確保するためには、潜在的な汚染物質の検出における正確性と信頼性が最も重要になります。

医薬品無菌試験市場レポートハイライト

  • タイプ別では、アウトソーシングセグメントが2023年に59.25%の最大売上シェアで市場をリードしました。このセグメントの成長を牽引しているのは、高品質の無菌試験を実施するためのインフラを持たない中小規模の製薬・医療機器企業数社にとって魅力的な選択肢として、無菌試験のアウトソーシングに対する要求が高まっていることです。
  • 製品タイプ別では、キット・試薬セグメントが2023年に60.30%の最大売上シェアを占め、市場をリードしました。
  • 試験タイプ別では、バイオバーデン試験セグメントが2023年に41.71%の最大売上シェアで市場をリードしました。このセグメントは、厳格な品質管理プロセスや、初期製造から最終流通までのさまざまな製造段階における製品の微生物汚染を定量化する試験の需要によって牽引されています。
  • サンプルベースでは、医薬品セグメントが2023年に42.45%の最大収益シェアで市場をリードしました。製品は広く使用されている剤形です。世界の需要の高まりやこれらの剤形は、このセグメントを牽引する主な要因の一つです。
  • 最終用途に基づくと、製薬会社が2023年の市場を独占しました。これらの企業は、製品の安全性、特に経口剤形の安全性を確保するために無菌試験を実施しています。
  • 北米が2023年の売上高シェア49.45%で市場を独占しました。この地域には多数の大手市場プレーヤーが存在するため、市場成長に大きく寄与すると予想されます。同地域では、医薬品や医療機器の無菌試験に対する規制要件が厳しいことも、市場の成長をさらに後押ししています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 医薬品無菌試験市場:タイプの推定・動向分析

  • 定義と範囲
  • セグメントダッシュボード
  • 世界の医薬品無菌試験市場の変動分析
  • 世界の医薬品無菌試験市場規模と動向分析、タイプ別、2018年から2030年

第4章 医薬品無菌試験市場:製品タイプの推定・動向分析

  • 定義と範囲
  • セグメントダッシュボード
  • 世界の医薬品無菌試験市場の変動分析
  • 世界の医薬品無菌試験市場規模と動向分析、製品タイプ別、2018年から2030年

第5章 医薬品無菌試験市場:試験タイプの推定・動向分析

  • 定義と範囲
  • セグメントダッシュボード
  • 世界の医薬品無菌試験市場の変動分析
  • 世界の医薬品無菌試験市場規模と動向分析、試験タイプ別、2018年から2030年

第6章 医薬品無菌試験市場:サンプルの推定・動向分析

  • 定義と範囲
  • セグメントダッシュボード
  • 世界の医薬品無菌試験市場の変動分析
  • 世界の医薬品無菌試験市場規模と動向分析、サンプル別、2018年から2030年

第7章 医薬品無菌試験市場:最終用途の推定・動向分析

  • 定義と範囲
  • セグメントダッシュボード
  • 世界の医薬品無菌試験市場の変動分析
  • 世界の医薬品無菌試験市場規模と動向分析、最終用途別、2018年から2030年

第8章 医薬品無菌試験市場:地域の推定・動向分析、タイプ別、製品タイプ別、試験タイプ別、サンプル別、最終用途別

  • 地域の市場ダッシュボード
  • 世界の地域の市場スナップショット
  • 市場規模と予測動向分析、2018年から2030年
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合情勢

  • 企業の分類
  • 医薬品無菌試験の市場シェア分析、2023年
  • 主要取引・戦略的提携分析
  • ベンダー情勢
    • Key company market share analysis, 2023
    • Pacific Biolabs
    • Steris Plc
    • Boston Analytical
    • Nelson Laboratories, LLC(Sotera Health)
    • Sartorius AG
    • SOLVIAS AG
    • SGS SA
    • Labcorp
    • Pace Analytical
    • Charles River Laboratories
    • Thermo Fisher Scientific, Inc.
    • Rapid Micro Biosystems
    • Almac Group
    • Labor LS SE &Co. KG
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Pharmaceutical Sterility Testing market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 5 North America Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 6 North America Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 7 North America Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 9 U.S. Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 12 U.S. Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Canada Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 15 Canada Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 16 Canada Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 17 Canada Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Europe Pharmaceutical Sterility Testing market, by region, 2018 - 2030 (USD Million)
  • Table 19 Europe Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 20 Europe Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 21 Europe Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 22 Europe Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 23 Europe Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 UK Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 25 UK Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 26 UK Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 27 UK Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 28 UK Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Germany Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 30 Germany Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 31 Germany Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 32 Germany Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 33 Germany Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 France Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 35 France Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 36 France Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 37 France Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 38 France Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Italy Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 40 Italy Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 41 Italy Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 42 Italy Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 43 Italy Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Spain Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 45 Spain Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 46 Spain Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 47 Spain Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 48 Spain Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Netherlands Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 50 Netherlands Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 51 Netherlands Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 52 Netherlands Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 53 Netherlands Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Switzerland Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 55 Switzerland Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 56 Switzerland Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 57 Switzerland Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 58 Switzerland Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Sweden Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 60 Sweden Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 61 Sweden Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 62 Sweden Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 63 Sweden Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Belgium Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 65 Belgium Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 66 Belgium Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 67 Belgium Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 68 Belgium Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Russia Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 70 Russia Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 71 Russia Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 72 Russia Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 73 Russia Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific Pharmaceutical Sterility Testing market, by region, 2018 - 2030 (USD Million)
  • Table 75 Japan Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 76 Japan Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 77 Japan Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 78 Japan Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 79 Japan Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 China Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 81 China Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 82 China Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 83 China Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 84 China Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 India Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 86 India Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 87 India Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 88 India Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 89 India Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 Australia Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 91 Australia Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 92 Australia Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 93 Australia Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 94 Australia Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 South Korea Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 96 South Korea Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 97 South Korea Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 98 South Korea Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 99 South Korea Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 100 Philippines Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 101 Philippines Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 102 Philippines Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 103 Philippines Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 104 Philippines Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 105 Malaysia Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 106 Malaysia Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 107 Malaysia Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 108 Malaysia Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 109 Malaysia Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 110 New Zealand Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 111 New Zealand Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 112 New Zealand Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 113 New Zealand Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 114 New Zealand Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 115 Singapore Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 116 Singapore Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 117 Singapore Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 118 Singapore Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 119 Singapore Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 120 Thailand Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 121 Thailand Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 122 Thailand Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 123 Thailand Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 124 Thailand Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 125 Latin America Pharmaceutical Sterility Testing market, by region, 2018 - 2030 (USD Million)
  • Table 126 Latin America Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 127 Latin America Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 128 Latin America Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 129 Latin America Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 130 Latin America Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 131 Brazil Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 132 Brazil Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 133 Brazil Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 134 Brazil Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 135 Brazil Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 136 Mexico Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 137 Mexico Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 138 Mexico Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 139 Mexico Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 140 Mexico Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 141 Argentina Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 142 Argentina Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 143 Argentina Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 144 Argentina Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 145 Argentina Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 146 Colombia Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 147 Colombia Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 148 Colombia Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 149 Colombia Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 150 Colombia Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 151 Chile Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 152 Chile Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 153 Chile Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 154 Chile Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 155 Chile Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 156 MEA Pharmaceutical Sterility Testing market, by region, 2018 - 2030 (USD Million)
  • Table 157 MEA Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 158 MEA Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 159 MEA Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 160 MEA Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 161 MEA Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 162 South Africa Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 163 South Africa Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 164 South Africa Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 165 South Africa Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 166 South Africa Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 167 Saudi Arabia Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 168 Saudi Arabia Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 169 Saudi Arabia Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 170 Saudi Arabia Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 171 Saudi Arabia Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 172 Egypt Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 173 Egypt Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 174 Egypt Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 175 Egypt Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 176 Egypt Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 177 Israel Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 178 Israel Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 179 Israel Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 180 Israel Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 181 Israel Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 182 UAE Pharmaceutical Sterility Testing market, by type, 2018 - 2030 (USD Million)
  • Table 183 UAE Pharmaceutical Sterility Testing market, by product type, 2018 - 2030 (USD Million)
  • Table 184 UAE Pharmaceutical Sterility Testing market, by test type, 2018 - 2030 (USD Million)
  • Table 185 UAE Pharmaceutical Sterility Testing market, by sample, 2018 - 2030 (USD Million)
  • Table 186 UAE Pharmaceutical Sterility Testing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Pharmaceutical sterility testing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-Chain-Based Sizing & Forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market outlook, 2023 (USD Million)
  • Fig. 17 Ancillary market outlook, 2023 (USD Million)
  • Fig. 18 Pharmaceutical sterility testing market dynamics
  • Fig. 19 Total R&D drug pipeline size, 2018 - 2023
  • Fig. 20 Total drug pipeline by development phase, 2023 vs. 2022
  • Fig. 21 Porter's five forces analysis
  • Fig. 22 PESTEL analysis
  • Fig. 23 Pharmaceutical sterility testing market type outlook: Segment dashboard
  • Fig. 24 Pharmaceutical sterility testing market, by type segment: Market share, 2023 & 2030
  • Fig. 25 Outsourcing market, 2018 - 2030 (USD Million)
  • Fig. 26 In-house market, 2018 - 2030 (USD Million)
  • Fig. 27 Pharmaceutical sterility testing market product type outlook: Segment dashboard
  • Fig. 28 Pharmaceutical sterility testing market, by product type segment: Market share, 2023 & 2030
  • Fig. 29 Kits and reagents market, 2018 - 2030 (USD Million)
  • Fig. 30 Instruments market, 2018 - 2030 (USD Million)
  • Fig. 31 Services market, 2018 - 2030 (USD Million)
  • Fig. 32 Pharmaceutical sterility testing market test type outlook: Segment dashboard
  • Fig. 33 Pharmaceutical sterility testing market, by test type segment: Market share, 2023 & 2030
  • Fig. 34 Sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 35 Membrane filtration market, 2018 - 2030 (USD Million)
  • Fig. 36 Direct inoculation market, 2018 - 2030 (USD Million)
  • Fig. 37 Product flush market, 2018 - 2030 (USD Million) Fig. 38 Bioburden testing market, 2018 - 2030 (USD Million)
  • Fig. 38 Bacterial endotoxin testing market, 2018 - 2030 (USD Million)
  • Fig. 39 Pharmaceutical sterility testing market sample outlook: Segment dashboard
  • Fig. 40 Pharmaceutical sterility testing market, by sample segment: Market share, 2023 & 2030
  • Fig. 41 Pharmaceuticals market, 2018 - 2030 (USD Million)
  • Fig. 42 Medical devices market, 2018 - 2030 (USD Million)
  • Fig. 43 Biopharmaceuticals market, 2018 - 2030 (USD Million)
  • Fig. 44 Pharmaceutical sterility testing market end use outlook: Segment dashboard
  • Fig. 45 Pharmaceutical sterility testing market, by end use segment: Market share, 2023 & 2030
  • Fig. 46 Compounding pharmacies market, 2018 - 2030 (USD Million) Fig. 48 Medical devices companies market, 2018 - 2030 (USD Million)
  • Fig. 47 Pharmaceutical companies' market, 2018 - 2030 (USD Million)
  • Fig. 48 Others market, 2018 - 2030 (USD Million)
  • Fig. 49 Regional market: Key takeaways
  • Fig. 50 Regional marketplace: Key takeaways
  • Fig. 51 Regional marketplace: Key takeaways
  • Fig. 52 Regional marketplace: Key takeaways
  • Fig. 53 North America pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 U.S. pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Canada pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 58 Europe pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 UK pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Germany pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 France pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Italy pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Spain pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Netherlands pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Switzerland pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Sweden pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Belgium pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Russia pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 79 Asia Pacific pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Japan pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 China pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 India pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Australia pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Clinical trial approval process in South Korea
  • Fig. 90 South Korea pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Singapore pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Malaysia pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Thailand pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Philippines pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 New Zealand pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 101 Latin America pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Brazil pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 104 Key country dynamics
  • Fig. 105 Mexico pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 106 Key country dynamics
  • Fig. 107 Argentina pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 108 Key country dynamics
  • Fig. 109 Colombia pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 110 Key country dynamics
  • Fig. 111 Chile pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 112 MEA pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 113 Key country dynamics
  • Fig. 114 South Africa pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 115 Key country dynamics
  • Fig. 116 Saudi Arabia pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 117 Key country dynamics
  • Fig. 118 Egypt pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 119 Key country dynamics
  • Fig. 120 Israel pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 121 Key country dynamics
  • Fig. 122 Clinical trial authorization process UAE
  • Fig. 123 UAE pharmaceutical sterility testing market, 2018 - 2030 (USD Million)
  • Fig. 124 Market participant categorization
  • Fig. 125 Market participant categorization
  • Fig. 126 Heat map analysis
目次
Product Code: GVR-2-68038-425-3

Pharmaceutical Sterility Testing Market Growth & Trends:

The global pharmaceutical sterility testing market size is anticipated to reach USD 3.28 billion by 2030 and is projected to grow at a CAGR of 11.02% from 2024 to 2030, according to a new report by Grand View Research, Inc. A growing number of drug launches worldwide, and rising government investments are anticipated to influence the global market positively. As pharmaceutical companies are introducing an array of new drugs to the market, there is a parallel surge in the demand for rigorous sterility testing protocols. Besides, stringent regulatory requirements for pharmaceuticals products further support market growth. Thus, an upsurge in novel drug launches provided unprecedented growth opportunities to the pharmaceutical sterility testing market.

In addition, increasing emphasis on R&D activities in the pharmaceutical industry profoundly impacts the pharmaceutical sterility testing market. As pharmaceutical companies are proactively involved in the discovery and development of innovative & advanced drug formulations, there is a growing need for robust sterility testing protocols to ensure the safety and efficacy of these products. R&D activities drive the development of new pharmaceuticals, biologics, and vaccines, necessitating comprehensive sterility testing methodologies to comply with regulatory requirements.

Furthermore, stringent regulations by regulatory bodies for pharmaceutical product approval prompt pharmaceutical companies to invest significantly in R&D to meet these evolving standards. As a result, the market experiences a surge in demand for state-of-the-art testing solutions to align with the regulatory landscape. For instance, in September 2023, Sartorius AG introduced a sterisart septum for sampling from a sterility testing unit. It is a closed system for testing based on the membrane filtration method that mitigates the risk of secondary contamination. Such service launches offered a competitive edge in the market.

Moreover, the pharmaceutical industry's commitment to addressing unmet medical needs and discovering innovative therapeutic avenues further amplifies the importance of robust sterility testing protocols. The need for accuracy & reliability in detecting any potential contaminants becomes paramount to ensure the safety and efficacy of these newly launched drugs.

Pharmaceutical Sterility Testing Market Report Highlights:

  • Based on type, the outsourcing segment led the market with the largest revenue share of 59.25% in 2023. The segment growth is driven by increasing requirements for Outsourcing sterility testing as attractive alternative for several small- & medium-sized pharmaceutical and medical device companies, which may lack the infrastructure to conduct quality sterility testing
  • Based on product type, the kits and reagents segment held the market with the largest revenue share of 60.30% in 2023, attributing to a standardized and reliable techniques to determine the absence of live microorganisms in pharmaceutical products
  • Based on test type, the bioburden testing segment led the market with the largest revenue share of 41.71% in 2023. The segment is driven by strict quality control processes and the demand for testing to quantify microbial contamination of a product at different stages of production from initial manufacturing to final distribution
  • Based on sample, the pharmaceuticals segment led the market with the largest revenue share of 42.45% in 2023. The products are widely used dosage forms. The growing demand or these dosage forms globally is one of the major factors driving this segment
  • Based on end-use, the pharmaceutical companies dominated the market in 2023. These companies conduct sterility tests to ensure the safety of the products, especially oral dosage forms, as most of these products are ingested by patients
  • North America dominated the market with a revenue share of 49.45% in 2023. The presence of a large number of major market players in this region is expected to contribute to the market growth significantly. Stringent regulatory requirements for sterility testing of pharmaceuticals and medical devices in this region further supports market growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates And Forecast Timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
    • 1.3.5. Details Of Primary Research
  • 1.4. Information Or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
    • 1.5.1. Region Wise Market: Base Estimates
    • 1.5.2. Global Market: CAGR Calculation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis (Model 1)
    • 1.6.2. Value-Chain-Based Sizing & Forecasting (Model 2)
    • 1.6.3. QFD Model Sizing & Forecasting (Model 3)
    • 1.6.4. Bottom-Up Approach (Model 4)
  • 1.7. Market Definitions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. List of Abbreviations
  • 1.11. Objectives
    • 1.11.1. Objective - 1
    • 1.11.2. Objective - 2
    • 1.11.3. Objective - 3
    • 1.11.4. Objective - 4

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot
  • 2.4. Market Lineage Outlook
    • 2.4.1. Parent Market Outlook
    • 2.4.2. Ancillary Market Outlook
  • 2.5. Pharmaceutical Sterility Testing Market Dynamics
    • 2.5.1. Market Driver Impact Analysis
      • 2.5.1.1. Supportive Government Investment In The Healthcare Industry
      • 2.5.1.2. Increasing R&D Activities
      • 2.5.1.3. Increasing Number Of Drug Launches
      • 2.5.1.4. Increasing Focus On Quality And Sterility
    • 2.5.2. Market Restraint Analysis
      • 2.5.2.1. Compliance Issues While Outsourcing
      • 2.5.2.2. Third Party Performance
  • 2.6. Pharmaceutical Sterility Testing Market: Analysis Tools
    • 2.6.1. Porter's Five Forces Analysis
    • 2.6.2. PESTEL Analysis
  • 2.7. Impact Of Covid-19 On Pharmaceutical Sterility Testing Market
  • 2.8. Post Covid-19 Reformation Strategies In The Market

Chapter 3. Pharmaceutical Sterility Testing Market: Type Estimates & Trend Analysis

  • 3.1. Definitions and Scope
    • 3.1.1. In-House
    • 3.1.2. Outsourcing
  • 3.2. Segment Dashboard
  • 3.3. Global Pharmaceutical Sterility Testing Market Movement Analysis
  • 3.4. Global Pharmaceutical Sterility Testing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
    • 3.4.1. In-House
      • 3.4.1.1. Market estimates and forecast 2018 to 2030 (USD million)
    • 3.4.2. Outsourcing
      • 3.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 4. Pharmaceutical Sterility Testing Market: Product Type Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Kits and Reagents
    • 4.1.2. Instruments
    • 4.1.3. Services
  • 4.2. Segment Dashboard
  • 4.3. Global Pharmaceutical Sterility Testing Market Movement Analysis
  • 4.4. Global Pharmaceutical Sterility Testing Market Size & Trend Analysis, by Product Type, 2018 to 2030 (USD Million)
    • 4.4.1. Kits and Reagents
      • 4.4.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.2. Instruments
      • 4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.3. Services
      • 4.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Pharmaceutical Sterility Testing Market: Test Type Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Sterility Testing
      • 5.1.1.1. Membrane Filtration
      • 5.1.1.2. Direct Inoculation
      • 5.1.1.3. Product Flush
    • 5.1.2. Bioburden Testing
    • 5.1.3. Bacterial Endotoxin Testing
  • 5.2. Segment Dashboard
  • 5.3. Global Pharmaceutical Sterility Testing Market Movement Analysis
  • 5.4. Global Pharmaceutical Sterility Testing Market Size & Trend Analysis, by Product Type, 2018 to 2030 (USD Million)
    • 5.4.1. Sterility Testing
      • 5.4.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 5.4.1.2. Membrane Filtration
      • 5.4.1.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 5.4.1.3. Direct Inoculation
      • 5.4.1.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 5.4.1.4. Product Flush
      • 5.4.1.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.2. Bioburden Testing
      • 5.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.3. Bacterial Endotoxin Testing
      • 5.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Pharmaceutical Sterility Testing Market: Sample Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Pharmaceuticals
    • 6.1.2. Medical Devices
    • 6.1.3. Biopharmaceuticals
  • 6.2. Segment Dashboard
  • 6.3. Global Pharmaceutical Sterility Testing Market Movement Analysis
  • 6.4. Global Pharmaceutical Sterility Testing Market Size & Trend Analysis, by Sample, 2018 to 2030 (USD Million)
    • 6.4.1. Pharmaceuticals
      • 6.4.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.2. Medical Devices
      • 6.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.3. Biopharmaceuticals
      • 6.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Pharmaceutical Sterility Testing Market: End-use Estimates & Trend Analysis

  • 7.1. Definitions and Scope
    • 7.1.1. Compounding Pharmacies
    • 7.1.2. Medical Device Companies
    • 7.1.3. Pharmaceutical Companies
    • 7.1.4. Others
  • 7.2. Segment Dashboard
  • 7.3. Global Pharmaceutical Sterility Testing Market Movement Analysis
  • 7.4. Global Pharmaceutical Sterility Testing Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
    • 7.4.1. Compounding Pharmacies
      • 7.4.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 7.4.2. Medical Device Companies
      • 7.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 7.4.3. Pharmaceutical Companies
      • 7.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 7.4.4. Others
      • 7.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Pharmaceutical Sterility Testing Market: Regional Estimates & Trend Analysis by Type, Product Type, Test Type, Sample, End-use

  • 8.1. Regional Market Dashboard
  • 8.2. Global Regional Market Snapshot
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Scenario
      • 8.4.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Scenario
      • 8.4.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Scenario
      • 8.5.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Scenario
      • 8.5.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Scenario
      • 8.5.4.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Scenario
      • 8.5.5.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Scenario
      • 8.5.6.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.7. Netherlands
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Scenario
      • 8.5.7.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.8. Switzerland
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Scenario
      • 8.5.8.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.9. Sweden
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Scenario
      • 8.5.9.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.10. Belgium
      • 8.5.10.1. Key Country Dynamics
      • 8.5.10.2. Competitive Scenario
      • 8.5.10.3. Regulatory Scenario
      • 8.5.10.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.11. Russia
      • 8.5.11.1. Key Country Dynamics
      • 8.5.11.2. Competitive Scenario
      • 8.5.11.3. Regulatory Scenario
      • 8.5.11.4. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Scenario
      • 8.6.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Scenario
      • 8.6.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Scenario
      • 8.6.4.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Scenario
      • 8.6.5.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Scenario
      • 8.6.6.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.7. Philippines
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Scenario
      • 8.6.7.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.8. Malaysia
      • 8.6.8.1. Key Country Dynamics
      • 8.6.8.2. Competitive Scenario
      • 8.6.8.3. Regulatory Scenario
      • 8.6.8.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.9. New Zealand
      • 8.6.9.1. Key Country Dynamics
      • 8.6.9.2. Competitive Scenario
      • 8.6.9.3. Regulatory Scenario
      • 8.6.9.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.10. Singapore
      • 8.6.10.1. Key Country Dynamics
      • 8.6.10.2. Competitive Scenario
      • 8.6.10.3. Regulatory Scenario
      • 8.6.10.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.11. Thailand
      • 8.6.11.1. Key Country Dynamics
      • 8.6.11.2. Competitive Scenario
      • 8.6.11.3. Regulatory Scenario
      • 8.6.11.4. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Scenario
      • 8.7.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.3. Mexico
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Scenario
      • 8.7.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.4. Argentina
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Scenario
      • 8.7.4.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.5. Colombia
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Scenario
      • 8.7.5.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.6. Chile
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Competitive Scenario
      • 8.7.6.3. Regulatory Scenario
      • 8.7.6.4. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Scenario
      • 8.8.2.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Scenario
      • 8.8.3.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.4. Egypt
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Scenario
      • 8.8.4.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.5. Israel
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Scenario
      • 8.8.5.4. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.6. UAE
      • 8.8.6.1. Key Country Dynamics
      • 8.8.6.2. Competitive Scenario
      • 8.8.6.3. Regulatory Scenario
      • 8.8.6.4. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Pharmaceutical Sterility Testing Market Share Analysis, 2023
  • 9.3. Major Deals and Strategic Alliances Analysis
    • 9.3.1. Strategy Mapping
    • 9.3.2. Expansion
    • 9.3.3. Partnerships
    • 9.3.4. Acquisitions
  • 9.4. Vendor Landscape
    • 9.4.1. Key company market share analysis, 2023
    • 9.4.2. Pacific Biolabs
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Steris Plc
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Boston Analytical
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Nelson Laboratories, LLC (Sotera Health)
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Sartorius AG
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. SOLVIAS AG
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. SGS SA
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Labcorp
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Pace Analytical
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Charles River Laboratories
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Thermo Fisher Scientific, Inc.
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. Rapid Micro Biosystems
      • 9.4.13.1. Company overview
      • 9.4.13.2. Financial performance
      • 9.4.13.3. Product benchmarking
      • 9.4.13.4. Strategic initiatives
    • 9.4.14. Almac Group
      • 9.4.14.1. Company overview
      • 9.4.14.2. Financial performance
      • 9.4.14.3. Product benchmarking
      • 9.4.14.4. Strategic initiatives
    • 9.4.15. Labor LS SE & Co. KG
      • 9.4.15.1. Company overview
      • 9.4.15.2. Financial performance
      • 9.4.15.3. Product benchmarking
      • 9.4.15.4. Strategic initiatives